Format

Send to

Choose Destination
Pharmacy (Basel). 2019 Apr 23;7(2). pii: E38. doi: 10.3390/pharmacy7020038.

Emergency Contraception Counseling in California Community Pharmacies: A Mystery Caller Study.

Author information

1
Department of Pharmacy, UC San Diego Health, San Diego 92103, CA, USA. lditmars@ucsd.edu.
2
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla 92093, CA, USA. lditmars@ucsd.edu.
3
Department of Pharmacy, UC San Diego Health, San Diego 92103, CA, USA. srafie@ucsd.edu.
4
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla 92093, CA, USA. srafie@ucsd.edu.
5
Birth Control Pharmacist, San Diego 92122, CA, USA. srafie@ucsd.edu.
6
Owl Rexall Drug, Glendora 91740, CA, USA. gkashou18@gmail.com.
7
Office of Population Research, Woodrow Wilson School of Public and International Affairs, Princeton University, Princeton 08540, NJ, USA. kcleland@princeton.edu.
8
Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland 97239, OR, USA. bayerl@ohsu.edu.
9
Children's Health Services Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis 46202, IN, USA. tracwilk@iu.edu.

Abstract

This study was conducted to determine which emergency contraception (EC) methods are offered by community pharmacists in response to patient calls. Female mystery callers called all community pharmacies in two California cities using standardized scripts. The callers inquired about options available to prevent pregnancy after sex and whether that method was available at the pharmacy, using follow-up probes if necessary. A total of 239 calls were completed in San Diego (n = 127, 53%) and San Francisco (n = 112, 47%). Pharmacists indicated availability at most sites (n = 220, 92%) with option(s) reported as levonorgestrel only (LNG; n = 211, 88.3%), both ulipristal acetate (UPA) and LNG (n = 4, 1.6%), UPA only (n = 1, 0.4%), or non-specific EC (n = 4, 1.7%). Nineteen pharmacies (7.9%) did not have EC available on the day of the call. Following additional probing, some pharmacists discussed UPA (n = 49, 20.5%) or the copper intrauterine device (n = 1, 0.4%) as EC options. LNG EC products were available same-day in 90.1% of pharmacies, whereas UPA was available same-day in 9.6% of pharmacies. The majority of pharmacies called in this study offered and stocked at least one EC option, but the focus of discussions was on LNG and matched what was in stock and available.

KEYWORDS:

emergency contraception; levonorgestrel; pharmacist; pharmacy; ulipristal acetate

Conflict of interest statement

Uysal, J.; Tavrow, P.; Hsu, R.; Alterman, A. Availability and accessibility of emergency contraception to adolescent callers in pharmacies in four Southwestern states. J. Adolesc. Health 2019, 64, 219–225.

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center